Lotus Bio-Technology Development Corp
Lotus Bio-Technology Development Corp. does not have significant operations. The company intends to seek opportunities in the Organic and Bio-technology space. Previously, it is engaged in refining organic materials, and production of natural consumer related products. The company was formerly known as Starflick.com and changed its name to Lotus Bio-Technology Development Corp. in April 2016. Lot… Read more
Lotus Bio-Technology Development Corp (LBTD) - Net Assets
Latest net assets as of March 2021: $-61.31K USD
Based on the latest financial reports, Lotus Bio-Technology Development Corp (LBTD) has net assets worth $-61.31K USD as of March 2021.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($55.46K) and total liabilities ($116.77K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-61.31K |
| % of Total Assets | -110.54% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Lotus Bio-Technology Development Corp - Net Assets Trend (2011–2017)
This chart illustrates how Lotus Bio-Technology Development Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Lotus Bio-Technology Development Corp (2011–2017)
The table below shows the annual net assets of Lotus Bio-Technology Development Corp from 2011 to 2017.
| Year | Net Assets | Change |
|---|---|---|
| 2017-03-31 | $-80.86K | -31.89% |
| 2016-03-31 | $-61.31K | -35.63% |
| 2015-03-31 | $-45.20K | +13.29% |
| 2014-03-31 | $-52.13K | -461.92% |
| 2013-03-31 | $-9.28K | +81.95% |
| 2012-03-31 | $-51.39K | -231.54% |
| 2011-03-31 | $-15.50K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Lotus Bio-Technology Development Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 93339900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2017)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $828.00 | % |
| Other Components | $886.81K | % |
| Total Equity | $-61.31K | 100.00% |
Lotus Bio-Technology Development Corp Competitors by Market Cap
The table below lists competitors of Lotus Bio-Technology Development Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dimet (Siam) Public Company Limited
BK:DIMET
|
$2.49 Million |
|
Baosheng Media Group Holdings Ltd
NASDAQ:BAOS
|
$2.49 Million |
|
YX Precious Metals Bhd
KLSE:0250
|
$2.49 Million |
|
Chaoprayamahanakorn Public Company Limited
BK:CMC
|
$2.49 Million |
|
PT Winner Nusantara Jaya Tbk
JK:WINR
|
$2.49 Million |
|
VANTEA SMART S.P.A.
F:9X2
|
$2.49 Million |
|
Augros Cosmetic Packaging SA
PA:AUGR
|
$2.49 Million |
|
Onfolio Holdings Inc
NASDAQ:ONFO
|
$2.49 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lotus Bio-Technology Development Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2016 to 2017, total equity changed from -61,308 to -61,308, a change of 0.
- Net loss of 19,550 reduced equity.
- Other factors increased equity by 19,550.
Equity Change Factors (2016 to 2017)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-19.55K | -31.89% |
| Other Changes | $19.55K | +31.89% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Lotus Bio-Technology Development Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-03-31 | $0.00 | $0.01 | x |
| 2012-03-31 | $-0.01 | $0.01 | x |
| 2013-03-31 | $0.00 | $0.01 | x |
| 2014-03-31 | $-0.01 | $0.01 | x |
| 2015-03-31 | $0.00 | $0.01 | x |
| 2016-03-31 | $0.00 | $0.01 | x |
| 2017-03-31 | $0.00 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lotus Bio-Technology Development Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-14.00K |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-30.75K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-61.21K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-36.43K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-14.20K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-774.87K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-13.42K |
Industry Comparison
This section compares Lotus Bio-Technology Development Corp's net assets metrics with peer companies in the Agricultural Inputs industry.
Industry Context
- Industry: Agricultural Inputs
- Average net assets among peers: $1,234,454,915
- Average return on equity (ROE) among peers: -88.72%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lotus Bio-Technology Development Corp (LBTD) | $-61.31K | 0.00% | N/A | $2.49 Million |
| Argo Living Soils Corp (ARLSF) | $117.11K | -241.15% | 0.57x | $4.77 Million |
| American Vanguard Corporation (AVD) | $282.36 Million | 4.53% | 0.52x | $93.02 Million |
| Bee Vectoring Technologies International Inc (BEVVF) | $1.82 Million | -170.52% | 0.16x | $47.51K |
| Benson Hill, Inc. Common Stock (BHIL) | $86.04 Million | -134.02% | 2.19x | $178.85K |
| BHILW (BHILW) | $86.04 Million | -134.02% | 2.19x | $286.16K |
| Bioceres Crop Solutions Corp (BIOX) | $351.38 Million | 0.92% | 1.43x | $16.37 Million |
| CO2 Gro Inc (BLONF) | $577.93K | -224.34% | 1.65x | $154.65K |
| China BlueChemical Ltd (CBLUF) | $7.05 Billion | 23.77% | 0.29x | $484.41 Million |
| CF Industries Holdings Inc (CF) | $4.39 Billion | 15.96% | 1.90x | $15.33 Billion |
| China Green Agriculture Inc (CGA) | $100.10 Million | -28.38% | 0.63x | $14.93 Million |